Aimed Alliance
Navigate
  • Home
  • About
    • Mission, Vision, Beliefs
    • Staff
    • Board of Directors
    • Aimed Alliance Supporters
    • Annual Reports
    • Privacy Policy
  • Policy Priorities
  • Initiatives
    • Alternative Funding Programs
    • Copay Accumulator 101
    • Judicial Advocacy
    • Know Your Rights
    • New York Step Therapy Reform
    • Prescription Drug Affordability Boards
  • Resources
    • All
    • Stakeholders
    • Aimed in the News
    • Health News & Lawsuits
    • Newsletters & Media
  • Maps
    • Bad Drug Ads
      • Active Legislation
      • Enacted Laws
    • Copay Accumulators
      • Active Legislation
      • Enacted Laws
    • Nonmedical Switching
      • Active Legislation
      • Enacted Laws
    • Prior Authorization
      • Active Legislation
      • Enacted Laws
    • Step Therapy
      • Active Legislation
      • Enacted Laws
    • Biomarker Testing
      • Active Legislation
      • Enacted Laws
    • Oral Parity
      • Enacted Laws
  • Events
  • Contact

Aimed Alliance Comments on Massachusetts’ Medicaid Section 1115 Waiver Request

0
By Aimed Alliance on October 20, 2017 Aimed Activity, Health Insurance Reform, Health Insurance Reforms:  Policy Activity, Policymakers

Aimed Alliance Comments on Massachusetts’ Medicaid Section 1115 Waiver Request. Read here.

 

Last Updated on May 10, 2019 by Aimed Alliance

Health Reform Medicaid State
Share. Twitter Facebook Pinterest LinkedIn Tumblr Email

Related Posts

  • August 4, 2025

    Aimed Alliance Urges Federal Action to Protect ACA Cost-Sharing and Drug Coverage Protections

  • August 4, 2025

    Aimed Alliance Urges MD PDAB to Conduct Patient-Centered, Evidence-Based Reviews

  • July 28, 2025

    White House AI Plan May Limit State Authority on AI

Comments are closed.

  • Aimed Alliance

  • Aimed Alliance is a 501 (c)(3) not-for-profit health policy organization that protects and enhances the rights of health care consumers and professionals.

    • Twitter
    • Facebook
    • Instagram
    • LinkedIn
    • YouTube